Registration statement for securities of certain foreign private issuers

Recapitalization Transaction Expense (Tables)

v3.22.1
Recapitalization Transaction Expense (Tables)
12 Months Ended
Dec. 31, 2021
Disclosure Of Recapitalization Transaction Expense [Abstract]  
Summary of Displays Calculation of Recapitalization Transaction Expense

The following table displays the calculation of the Recapitalization transaction expense:

Number of 

    

Amount

    

shares/warrants

$’000

(a) Alkuri Ordinary Shares

 

  

 

12,267,653

(b) Opening price of Babylon Ordinary Shares on NYSE as of October 22, 2021

 

10.01

 

  

(c) Fair value of Company shares issued to Alkuri shareholders (a*b)

 

122,799

 

  

(d) Outstanding Alkuri Warrants on October 22, 2021

 

  

 

14,558,333

(e) Opening price of Babylon Warrants on NYSE as of October 22, 2021

 

  

 

  

Public warrants

 

2.13

 

8,625,000

Private placement warrants

 

2.13

 

5,933,333

(f) Fair value of outstanding Alkuri Warrants (d*e)

 

31,009

 

  

Total fair value of Alkuri Ordinary Shares and Alkuri Warrants (c+f)

 

153,808

 

  

Alkuri’s identifiable net assets

 

5,310

 

  

IFRS 2 Expense on the closing date

 

148,498

 

  

PIPE Transaction

 

  

 

  

(a) PIPE Ordinary Shares

 

  

 

22,400,000

(b) Opening price of Babylon Ordinary Shares on NYSE as of October 22, 2021

 

10.01

 

  

(c) Fair value of Company shares issued to PIPE investors (a*b)

 

224,224

 

  

PIPE’s identifiable net assets

 

224,000

 

  

IFRS 2 Expense on the closing date

 

224

 

  

Total IFRS 2 Expense

 

148,722

 

  

Total cash proceeds received

 

229,311

 

  

Expense of share issue

 

(32,787)

 

  

Cash proceeds

 

196,524